Results 1 to 10 of about 14,431 (203)
Psychedelics and Psychedelic-Assisted Psychotherapy
American Journal of Psychiatry, 2020 The authors provide an evidenced-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders.Searches of PubMed and PsycINFO via Ovid were conducted for articles in English, in peer-reviewed journals, reporting on "psilocybin," "lysergic acid diethylamide," "LSD," "ayahuasca," "3,4 ...
Charles B Nemeroff +2 more
exaly +5 more sources
Pharmacological Reviews, 2016 Psychedelics (serotonergic hallucinogens) are powerful psychoactive substances that alter perception and mood and affect numerous cognitive processes. They are generally considered physiologically safe and do not lead to dependence or addiction. Their origin predates written history, and they were employed by early cultures in many sociocultural and ...
David E Nichols
exaly +3 more sources
Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community [PDF]
Harm Reduction JournalBackground The use of psychedelics is currently increasing in the United States. Awareness of clinical trials investigating the therapeutic applications of psychedelics may result in a record number of people who use psychedelics for the first-time. This
Daniel J. Kruger +7 more
doaj +2 more sources
Virtual reality and psychedelics: new perspectives and new possibilities in the treatment of alcohol use disorder [PDF]
Frontiers in PsychiatryPsychedelic-assisted therapy is a remarkably promising treatment for substance use disorders and for alcohol use disorder (AUD) in particular. Research supporting psychedelics as a safe and effective pharmacotherapy for AUD and its comorbid psychiatric ...
Scott Matthews +11 more
doaj +2 more sources
Current Biology, 2022 Psychedelics are compounds that alter consciousness by acting on serotonin receptors in the brain. The term 'psychedelic', from the Greek for mind manifesting, refers to the drugs' subjective effects and was first proposed by Humphry Osmond in 1956. Other terms have been used to emphasize different aspects of the psychological experiences produced by ...
Benjamin, Kelmendi +3 more
openaire +3 more sources
Frontiers in Pharmacology, 2023 Introduction:N-2-methoxy-benzylated (“NBOMe”) analogues of phenethylamine are a group of new psychoactive substances (NPS) with reported strong psychedelic effects in sub-milligram doses linked to a number of severe intoxications, including fatal ones ...
Kateřina Syrová +20 more
doaj +1 more source
Medical student attitudes and perceptions of psychedelic-assisted therapies
Frontiers in Psychiatry, 2023 IntroductionAlthough certain psychedelic agents may soon gain federal approval for use in treating specific psychiatric conditions, the utilization of such therapies in clinical practice will depend largely on the attitudes of healthcare providers ...
Irene Li +5 more
doaj +1 more source
Effects of classic psychedelic drugs on turbulent signatures in brain dynamics
Network Neuroscience, 2022 Psychedelic drugs show promise as safe and effective treatments for neuropsychiatric disorders, yet their mechanisms of action are not fully understood.
Josephine Cruzat +12 more
doaj +1 more source
The association between naturalistic use of psychedelics and co-occurring substance use disorders
Frontiers in Psychiatry, 2023 ObjectiveClassic psychedelics (LSD, psilocybin, and peyote/mescaline) have been used to support addiction treatment in a variety of contexts ranging from ceremonial use to clinical trials.
Jonina Rabinowitz +6 more
doaj +1 more source
Classic psychedelics do not affect T cell and monocyte immune responses
Frontiers in Psychiatry, 2023 IntroductionClassic psychedelics have been shown to exert therapeutic potential for the treatment of various psychiatric disorders, neuropsychiatric diseases, and neuronal damage.
Deborah Rudin +5 more
doaj +1 more source